Aurobindo, Hetero, and Vivimed Class Action Settlements in North Carolina
Aurobindo, Hetero, and Vivimed class action settlements that covered North Carolina residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
North Carolina residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for North Carolina Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in North Carolina
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
North Carolina residents affected by contaminated blood pressure medications from Aurobindo Pharma, Hetero Labs, and Vivimed Life Sciences have specific protections under state law. The North Carolina Unfair and Deceptive Trade Practices Act (UDTPA) provides broader consumer protections than federal regulations, allowing residents to pursue additional damages beyond standard class action recoveries. Aurobindo maintains significant U.S. operations through its New Jersey facilities, while Hetero and Vivimed distribute medications throughout North Carolina via major pharmacy chains including CVS, which has substantial presence in the state with over 600 locations. North Carolina's pharmaceutical distribution network means these companies' products reached consumers statewide through retail pharmacies, hospitals, and mail-order services. The state's consumer protection framework requires detailed disclosure of potential contamination risks, making manufacturers potentially liable under UDTPA violations. North Carolina residents filing class action claims benefit from the state's four-year statute of limitations for UDTPA violations, which may extend beyond federal deadlines. The state's "automatic stay" provisions also protect residents from losing claims due to bankruptcy proceedings involving pharmaceutical companies.
Aurobindo, Hetero, and Vivimed Settlements in North Carolina: FAQs
How does the $15.2M Valsartan, Losartan and Irbesartan settlement affect North Carolina residents who purchased medications from Aurobindo, Hetero, or Vivimed?
North Carolina residents who purchased contaminated blood pressure medications manufactured by these companies between 2012-2018 may be eligible for compensation from the settlement fund. The settlement covers medications containing NDMA and NDEA carcinogens that were distributed through North Carolina pharmacies. Residents must submit proof of purchase or pharmacy records to qualify for their share of the settlement.
Can North Carolina residents file additional claims under state law against Aurobindo, Hetero, and Vivimed beyond the federal class action?
Yes, North Carolina's Unfair and Deceptive Trade Practices Act allows residents to pursue separate claims for damages not covered in federal settlements. The UDTPA permits recovery of actual damages, treble damages in some cases, and attorney fees. However, residents should consult attorneys about potential conflicts with existing class action participation.
What documentation do North Carolina residents need to file claims against these pharmaceutical companies?
North Carolina residents need pharmacy records, prescription bottles, insurance statements, or receipts showing purchase of affected Valsartan, Losartan, or Irbesartan medications from 2012-2018. Medical records documenting health issues potentially linked to contaminated medications strengthen claims. CVS, Walgreens, and other major North Carolina pharmacy chains can provide historical prescription records upon request.
Tips for North Carolina Residents Filing Aurobindo, Hetero, and Vivimed Claims
North Carolina residents filing claims against Aurobindo, Hetero, and Vivimed should gather all pharmacy records from 2012-2018 showing purchases of affected blood pressure medications. Contact your pharmacy directly for detailed prescription histories, as North Carolina law requires pharmacies to maintain seven years of records. File claims promptly despite North Carolina's four-year UDTPA statute of limitations, as federal settlement deadlines may be shorter. Consider consulting North Carolina attorneys familiar with pharmaceutical litigation, as the state's consumer protection laws may provide additional remedies beyond federal class actions. Keep copies of all medical records showing potential health impacts from contaminated medications, and monitor ongoing litigation developments as additional settlements may emerge.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
